Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor?
OBJECTIVE--To compare the activity of plasminogen activator inhibitor (PAI-1) in diabetic and non-diabetic patients admitted with acute myocardial infarction and to determine whether PAI-1 activity influences reperfusion after thrombolytic therapy. DESIGN--Prospective study of patients admitted with...
Na minha lista:
| Publicado no: | Br Heart J |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1993
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1025384/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8280517/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.70.6.530 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|